ASPIRE BIOPHARMA HOLDINGS, INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) had Stock Issued During Period, Shares, Conversion of Convertible Securities of 5.74 million shares as of 2025-01-21, per its 10-Q filed 2025-11-14.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2025-11-14
- 2025-01-21: Stock Issued During Period, Shares, Conversion of Convertible Securities 5.74M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities |
|---|---|
| 2025-01-21 | 5.74M shares 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |